Cargando…

VEGF-Expressing Mesenchymal Stem Cell Therapy for Safe and Effective Treatment of Pain in Parkinson’s Disease

Vascular endothelial growth factor (VEGF) is a pro-angiogenic factor that mediates the differentiation and function of vascular endothelial cells. VEGF has been implicated in modulating various pains. However, the effects of VEGF in Parkinson’s disease (PD)-related pain have not been studied. The go...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Man, Li, Ji, Chen, Hong, Zhu, Mingxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841873/ https://www.ncbi.nlm.nih.gov/pubmed/36635947 http://dx.doi.org/10.1177/09636897221149130

Ejemplares similares

Mesenchymal stem cells for regenerative medicine in central nervous system
por: Li, Man, et al.
Publicado: (2022)

GDNF Promotes Survival and Therapeutic Efficacy of Human Adipose-Derived Mesenchymal Stem Cells in a Mouse Model of Parkinson’s Disease
por: Sun, Shoujia, et al.
Publicado: (2020)

VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma
por: Beckermann, B M, et al.
Publicado: (2008)

Parkinson's Disease and Mesenchymal Stem Cells: Potential for Cell-Based Therapy
por: Kitada, Masaaki, et al.
Publicado: (2012)

Genetically engineered mesenchymal stem cells with dopamine synthesis for Parkinson’s disease in animal models
por: Li, Jun, et al.
Publicado: (2022)

Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma
por: Li, Man, et al.
Publicado: (2019)

Mesenchymal stem cells, implications for pain therapy
por: Trallori, Elena, et al.
Publicado: (2019)

The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment
por: Heris, Reza Mosaddeghi, et al.
Publicado: (2022)

Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson’s disease
por: Fričová, Dominika, et al.
Publicado: (2020)

The potential therapy with dental tissue-derived mesenchymal stem cells in Parkinson’s disease
por: Xiao, Zhuangzhuang, et al.
Publicado: (2021)

Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury
por: Hu, Chenxia, et al.
Publicado: (2020)

Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease
por: Zhuo, Yi, et al.
Publicado: (2023)

Mechanism of Mesenchymal Stem Cells as a Multitarget Disease-Modifying Therapy for Parkinson's Disease
por: Unnisa, Aziz, et al.
Publicado: (2023)

Bone mesenchymal stem cells co-expressing VEGF and BMP-6 genes to combat avascular necrosis of the femoral head
por: Liao, Hongxing, et al.
Publicado: (2018)

Exosomes Derived from Mesenchymal Stem Cells Suppress Angiogenesis by Down-Regulating VEGF Expression in Breast Cancer Cells
por: Lee, Jong-Kuen, et al.
Publicado: (2013)

Beneficial effects of intramyocardial mesenchymal stem cells and VEGF(165) plasmid injection in rats with furazolidone induced dilated cardiomyopathy
por: Yu, Qin, et al.
Publicado: (2015)

MicroRNA-377 Regulates Mesenchymal Stem Cell-Induced Angiogenesis in Ischemic Hearts by Targeting VEGF
por: Wen, Zhili, et al.
Publicado: (2014)

Musculoskeletal Pain in Parkinson's Disease
por: Li, Jun, et al.
Publicado: (2022)

Update on the application of mesenchymal stem cell-derived exosomes in the treatment of Parkinson's disease: A systematic review
por: Liu, Shu-fen, et al.
Publicado: (2022)

Locally injected Mesenchymal Stem Cells optimize angiogenesis by regulating VEGF and CD31 expression in duodenal perforation
por: Setiawan, Eko, et al.
Publicado: (2022)

Painful Understanding of VEGF
por: Llorián-Salvador, María, et al.
Publicado: (2018)

VEGF treatment promotes bone marrow-derived CXCR4(+) mesenchymal stromal stem cell differentiation into vessel endothelial cells
por: Li, Qiming, et al.
Publicado: (2017)

Bone regeneration of mouse critical-sized calvarial defects with human mesenchymal stem cell sheets co-expressing BMP2 and VEGF
por: Guo, Tingting, et al.
Publicado: (2023)

The Yin and Yang of VEGF and PEDF: Multifaceted Neurotrophic Factors and Their Potential in the Treatment of Parkinson’s Disease
por: Falk, Torsten, et al.
Publicado: (2010)

Activation of the AT1R/HIF-1α/ACE Axis Mediates Angiotensin II-Induced VEGF Synthesis in Mesenchymal Stem Cells
por: Liu, Chao, et al.
Publicado: (2014)

Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial
por: Sun, Qipeng, et al.
Publicado: (2018)

Pharmacologically active microcarriers influence VEGF-A effects on mesenchymal stem cell survival
por: Penna, Claudia, et al.
Publicado: (2013)

Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia
por: Beegle, Julie R, et al.
Publicado: (2016)

VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing
por: Meeson, Richard, et al.
Publicado: (2018)

Development of VEGF-loaded PLGA matrices in association with mesenchymal stem cells for tissue engineering
por: Rosa, A.R., et al.
Publicado: (2017)

WNT and VEGF/PDGF signaling regulate self-renewal in primitive mesenchymal stem cells
por: Mazzella, Matteo, et al.
Publicado: (2023)

Immortalized Mesenchymal Stem Cells: A Safe Cell Source for Cellular or Cell Membrane-Based Treatment of Glioma
por: Zhang, Yuxuan, et al.
Publicado: (2022)

Protein Expression of Mesenchymal Stem Cells after Transfection of pcDNA3.1(−)-hVEGF(165) by Ultrasound-Targeted Microbubble Destruction
por: Pu, Zhaoxia, et al.
Publicado: (2011)

Stem cell transplantation therapy in Parkinson’s disease
por: Fu, Mu-Hui, et al.
Publicado: (2015)

Targeted Genome Engineering to Control VEGF Expression in Human Umbilical Cord Blood‐Derived Mesenchymal Stem Cells: Potential Implications for the Treatment of Myocardial Infarction
por: Cho, Hyun‐Min, et al.
Publicado: (2017)

Stem cell therapy for Parkinson's disease
por: Björklund, Lars M.
Publicado: (2004)

Effects of BMP2 and VEGF165 on the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells
por: LIN, ZHAOWEI, et al.
Publicado: (2014)

Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson’s Disease
por: d’Angelo, Michele, et al.
Publicado: (2020)

How Vascular Endothelial Growth Factor-A (VEGF) Regulates Differentiation of Mesenchymal Stem Cells
por: Berendsen, Agnes D., et al.
Publicado: (2014)

Adenoviral Delivery of the VEGF and BMP-6 Genes to Rat Mesenchymal Stem Cells Potentiates Osteogenesis
por: Seamon, Jesse, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_akokdpk7or7931knqu28h2m01o